Evidence map›Paper›PMID 21437992›Full record

ArticleSynapse (New York, N.Y.)2011

The contribution of low-affinity transport mechanisms to serotonin clearance in synaptosomes.

Catherine E Hagan, James O Schenk, John F Neumaier

Open access · greenAbstract read
In one paragraph

Article in Synapse (New York, N.Y.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Cardiac Roles of Serotonin (5-HT) and 5-HT-Receptors in Health and Disease.International journal of molecular sciences · 2023
    Review
  3. Review
  4. Review
  5. Organic Cation Transporters in Psychiatric Disorders.Handbook of experimental pharmacology · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Immunomodulatory effects mediated by serotonin.Journal of immunology research · 2015
    Review
  10. Article
  11. Decynium-22 enhances SSRI-induced antidepressant-like effects in mice: uncovering novel targets to treat depression.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Article
  12. Article
  13. Monitoring serotonin signaling on a subsecond time scale.Frontiers in integrative neuroscience · 2013
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Catherine E HaganDepartment of Comparative Medicine, University of Washington, Seattle, Washington 98195, USA. cehagan@u.washington.edu
James O Schenk
John F Neumaier
University of Washington · USWashington State University · US

Funding

5-HT1B Autoreceptors in Animal Models of Stress DisordersR01MH063303 · NIMH · UNIVERSITY OF WASHINGTON · PI NEUMAIER, JOHN F · 2001 to 2010
$2.5M
COMPARATIVE MEDICINET32RR007019 · NCRR · UNIVERSITY OF WASHINGTON · PI LIGGITT, HARRY DENNY · 1985 to 2006
$2.1M
Serotonergic Immunomodulation in Neuroinflammatory DiseaseK01RR024471 · NCRR · UNIVERSITY OF WASHINGTON · PI HAGAN, CATHERINE ELIZABETH · 2008 to 2011
$487k
NCRR NIH HHS K01 RR024471NCRR NIH HHS T32 RR007019NCRR NIH HHS T32 RR07019NIMH NIH HHS R01 MH063303NIMH NIH HHS R01 MH63303
6 · The paper itself

Abstract

Although many studies assert that the serotonin (5-HT) transporter (SERT) is the predominant mechanism controlling extracellular 5-HT concentrations, accumulating evidence suggests that low affinity, high capacity transport mechanisms may contribute more to 5-HT clearance than previously thought. The goal of this study was to quantify the contributions of SERT relative to other mechanisms in clearing extracellular 5-HT concentrations ranging from 50 nM to 1 μM in synaptosomes prepared from wild-type and SERT knockout mice using rotating disk electrode voltammetry. SERT inhibitors combined with decynium-22 (D-22), a blocker of several low-affinity transporters, blocked all uptake of 5-HT into synaptosomes. We found that SERT is responsible for the majority of synaptosomal uptake only at relatively low 5-HT concentrations, but comprises a diminishing proportion of 5-HT clearance when extracellular 5-HT increases above 100 nM. The effect of D-22 was similar in wild-type and SERT knockout synaptosomes. Thus, there was no evidence of upregulation of low-affinity mechanisms in knockout mice across the concentrations of 5-HT tested. These are surprising results, in light of the prevailing view that SERT is the primary uptake mechanism for extracellular 5-HT at physiological concentrations. We conclude that non-SERT mediated 5-HT uptake is substantial even at modest 5-HT concentrations. These findings, in conjunction with other studies, have important implications for understanding serotonergic disorders and may explain the variable efficacy and stability of patients' responses to antidepressants, such as the selective serotonin reuptake inhibitors.

Indexed as

AnimalsBinding SitesElectrochemical TechniquesFemaleMaleMetabolic Clearance RateMiceMice, Inbred C57BLMice, KnockoutParoxetinePresynaptic TerminalsQuinolinesSelective Serotonin Reuptake InhibitorsSerotoninSerotonin Plasma Membrane Transport ProteinsSynapsesParoxetinepseudoisocyanineQuinolinesSelective Serotonin Reuptake InhibitorsSerotoninSerotonin Plasma Membrane Transport Proteins

Identifiers

PMID21437992
PMCPMC3149756
OpenAlexW2067131027

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.